Bioceres Crop Solutions (BIOX) to Release Earnings on Wednesday

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) is anticipated to issue its quarterly earnings data before the market opens on Wednesday, February 12th. Analysts expect the company to announce earnings of $0.14 per share and revenue of $140.00 million for the quarter. Persons that wish to listen to the company's earnings conference call can do so using this link.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last released its quarterly earnings data on Monday, November 11th. The company reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of $0.02 by ($0.11). Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. The business had revenue of $92.60 million during the quarter, compared to the consensus estimate of $117.15 million. During the same period last year, the business posted ($0.07) earnings per share. On average, analysts expect Bioceres Crop Solutions to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Bioceres Crop Solutions Stock Down 0.5 %

Shares of Bioceres Crop Solutions stock traded down $0.03 during trading hours on Friday, reaching $5.55. The company's stock had a trading volume of 674,980 shares, compared to its average volume of 217,854. Bioceres Crop Solutions has a one year low of $5.50 and a one year high of $14.05. The company has a market capitalization of $348.04 million, a P/E ratio of 277.64 and a beta of 0.57. The stock's fifty day simple moving average is $6.62 and its two-hundred day simple moving average is $7.82. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.87 and a current ratio of 1.27.

Analysts Set New Price Targets

A number of research firms have weighed in on BIOX. Oppenheimer dropped their price objective on shares of Bioceres Crop Solutions from $13.00 to $12.00 and set an "outperform" rating on the stock in a research note on Tuesday, January 28th. Canaccord Genuity Group lowered their target price on shares of Bioceres Crop Solutions from $9.50 to $7.00 and set a "buy" rating for the company in a report on Friday. Finally, Lake Street Capital lowered their target price on shares of Bioceres Crop Solutions from $13.00 to $8.00 and set a "buy" rating for the company in a report on Friday. Four research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, Bioceres Crop Solutions currently has an average rating of "Buy" and a consensus price target of $10.00.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.